Display Settings:

Format

Send to:

Choose Destination
    Science. 2005 Jul 1;309(5731):148-50.

    Identification of a universal Group B streptococcus vaccine by multiple genome screen.

    Source

    Chiron srl, Via Fiorentina 1, 53100 Siena, Italy.

    Abstract

    Group B Streptococcus (GBS) is a multiserotype bacterial pathogen representing a major cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we analyzed the genome sequences of eight GBS isolates and cloned and tested 312 surface proteins as vaccines. Four proteins elicited protection in mice, and their combination proved highly protective against a large panel of strains, including all circulating serotypes. Protection also correlated with antigen accessibility on the bacterial surface and with the induction of opsonophagocytic antibodies. Multigenome analysis and screening described here represent a powerful strategy for identifying potential vaccine candidates against highly variable pathogens.

    PMID:
    15994562
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1351092
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Fig. 1

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk